article thumbnail

Roche CEO Severin Schwan to stand down after 14 years

pharmaphorum

The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.

Sales 119
article thumbnail

Personal responsibility in the obesity epidemic

World of DTC Marketing

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. That’s about $375 per month.

Food 207
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4mn dose shortage of GSK’s childhood rotavirus vaccine expected

European Pharmaceutical Review

“GSK communicated to GAVI earlier this year on manufacturing challenges leading to an unplanned, short-term drop in Rotarix production for 2022, for which priority mitigation plans are fully in place,” stated the publication. First dose measles coverage dropped to 81 percent in 2021, the lowest level since 2008, meaning 24.7

article thumbnail

Five Years of Forbes | Legacy MEDSearch Ranks on the Forbes Best Executive Recruitment Firms for a Fifth Consecutive Year

Legacy MEDSearch

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). All votes must be from someone within the industry to count in the totals.

article thumbnail

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

In this Q&A, he explores the trends and challenges within the cardiovascular treatment space, as well as clinical development of the company’s lead candidate obicetrapib, a cholesterol ester transfer protein (CETP) inhibitor for lowering low-density lipoprotein-cholesterol (LDL-C) and ultimately reducing cardiovascular risk.

Pharma 97
article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe” The closure of API manufacturing plants in Europe started in earnest 15 years ago.

Medicine 111
article thumbnail

Eureka Institute to show what translational medicine can do for digital health

pharmaphorum

The group will be leading a workshop on the topic at Frontiers Health next week. Albani and his cofounder Berent Prakken have been working in this field since 2008, applying translational thinking to the many seismic shifts that have happened in that time. Unifying varied stakeholders. Translational medicine and digital health.

Medicine 111